Taberna, M., Torres Tarrés, M., Alejo, M., Mena, M., Tous, S., Marquez, S., . . . Bravo, I. G. (2018). The use of HPV16-E5, EGFR, and PEGFR as prognostic biomarkers for oropharyngeal cancer patients.
Citación estilo ChicagoTaberna, Miren|||0000-0002-2446-186X, et al. The Use of HPV16-E5, EGFR, and PEGFR As Prognostic Biomarkers for Oropharyngeal Cancer Patients. 2018.
Cita MLATaberna, Miren|||0000-0002-2446-186X, et al. The Use of HPV16-E5, EGFR, and PEGFR As Prognostic Biomarkers for Oropharyngeal Cancer Patients. 2018.
Precaución: Estas citas no son 100% exactas.